Clinical randomized controlled trial of aspirin in the treatment of pregnancy complicated with adenomyosis on reducing preterm delivery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037659

Enrollment

Unknown

Registered

2020-08-29

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pregnancy complicated with adenomyosis

Interventions

experimental group :Asprin

control group:placebo

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Singleton; 2. in line with the diagnosis of adenomyosis in pregnancy; 3. no history of chronic diseases and definite diagnosis of endocrine diseases, including diabetes, hypertension, obesity, antiphospholipid syndrome; 4. informed consent and voluntary participation in this study.

Exclusion criteria

Exclusion criteria: 1. induced labor for medical reasons; 2. allergic to aspirin or other salicylates, tetracycline drugs or any other components of drugs; 3. patients with mental disorders; 4. transferred to hospital.

Design outcomes

Primary

Measure	Time frame
premature delivery;	—

Secondary

Measure	Time frame
abortion;	—

Countries

China

Contacts

Public ContactDu Qiaoling

Shanghai First Maternity And Infant Hospital

liu18352424272@163.com+86 15021628612

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026